Media coverage about Shire PLC (NASDAQ:SHPG) has trended somewhat positive on Wednesday, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Shire PLC earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave news stories about the biopharmaceutical company an impact score of 45.2697715371508 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news stories that may have effected Accern’s scoring:
- It’s Official: Shire Takes Over Ariad’s Old Space in Kendall Square (intelligent-aerospace.com)
- Shire Plc :SHPG-US: Earnings Analysis: Q2, 2017 By the Numbers : October 9, 2017 (finance.yahoo.com)
- Shire PLC (SHPG) Rating Reiterated by Stifel Nicolaus (americanbankingnews.com)
- Shire PLC (SHPG) Given Average Recommendation of “Buy” by Brokerages (americanbankingnews.com)
A number of analysts have recently issued reports on SHPG shares. Piper Jaffray Companies set a $159.00 target price on Shire PLC and gave the stock a “hold” rating in a report on Wednesday, July 26th. ValuEngine cut Shire PLC from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Zacks Investment Research cut Shire PLC from a “hold” rating to a “sell” rating in a report on Monday, July 17th. BidaskClub cut Shire PLC from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Finally, Royal Bank Of Canada set a $213.00 price target on Shire PLC and gave the stock a “buy” rating in a report on Friday, August 4th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and thirteen have assigned a buy rating to the company. Shire PLC currently has an average rating of “Buy” and an average price target of $220.91.
Shire PLC (SHPG) opened at 151.50 on Wednesday. Shire PLC has a 1-year low of $139.36 and a 1-year high of $192.64. The stock’s 50 day moving average price is $152.69 and its 200 day moving average price is $165.51. The stock has a market capitalization of $45.12 billion, a PE ratio of 67.79 and a beta of 1.63.
Shire PLC (NASDAQ:SHPG) last released its earnings results on Friday, October 27th. The biopharmaceutical company reported $3.37 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $3.66 by ($0.29). Shire PLC had a net margin of 4.70% and a return on equity of 14.10%. Equities research analysts forecast that Shire PLC will post $14.93 earnings per share for the current year.
The company also recently disclosed a semiannual dividend, which will be paid on Friday, October 20th. Stockholders of record on Friday, September 8th will be issued a dividend of $0.1527 per share. This represents a dividend yield of 0.21%. The ex-dividend date is Thursday, September 7th. Shire PLC’s payout ratio is presently 41.07%.
WARNING: This article was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://sportsperspectives.com/2017/10/11/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-shire-plc-shpg-share-price.html.
About Shire PLC
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.